Previous Article | Next Article ![]()
Infection and Immunity, January 2001, p. 564-569, Vol. 69, No. 1
Department of Clinical Sciences, College of
Veterinary Medicine, North Carolina State University, Raleigh,
North Carolina 27606
Received 5 June 2000/Returned for modification 24 August
2000/Accepted 5 October 2000
Bartonella henselae is known to cause central nervous
system (CNS) disease in humans, and neurological signs have been
observed in experimentally infected cats. However, the pathogenesis of CNS disease remains unclear. This study was undertaken to determine whether B. henselae infects feline fetal brain cells in
vitro. Microglial-cell- and astrocyte-enriched cultures were inoculated with B. henselae. Giménez staining identified
bacterial organisms within microglial cells by day 7 postinoculation.
The viability of the intracellular bacteria was demonstrated by
incubating cultures with gentamicin and plating cell lysate on agar.
Electron microscopy identified intracellular organisms with
characteristic Bartonella morphology but identified no
ultrastructural abnormalities within infected microglial cells. No
evidence of infection was seen in Bartonella-inoculated
astrocyte cultures. These findings suggest a role for microglia in the
pathogenesis of B. henselae-associated neurological disease.
Bartonella henselae, a
bacterial pathogen first identified in 1990, is the cause of an
expanding spectrum of clinical syndromes in human patients, including
cat scratch disease, bacillary angiomatosis, bacillary peliosis
hepatis, endocarditis, and relapsing bacteremia. Central nervous system
(CNS) involvement can occur in conjunction with many of these
disorders. Neurologic sequelae of cat scratch disease include
encephalopathy, myelopathy, meningitis, cerebral arteritis, optic
neuritis, and radiculopathy (2, 4, 21, 27, 32). Cerebral
bacillary angiomatosis has been reported in human immunodeficiency
virus (HIV)-infected patients (34), and aseptic meningitis
has been described in association with relapsing B. henselae
bacteremia (22). In addition, two recent studies suggest a
role for B. henselae in the development of AIDS-related neurological disease: B. henselae-specific antibodies have
been identified in the cerebrospinal fluid (CSF) of HIV patients
presenting with neurological disease (30), and
HIV-associated dementia has been associated with serum antibodies to
B. henselae (31). Despite the growing number of
reports implicating B. henselae in the development of
neurological disease, the pathogenesis of CNS dysfunction remains unclear.
Epidemiological studies have established that cat exposure is a risk
factor for B. henselae-associated disease in humans
(35, 39) and that Bartonella infection in cats
is widespread. Seroprevalence of B. henselae antibodies in
cats has been reported to be as high as 54% (13). In
regions of the world where fleas are endemic, the prevalence of
bacteremia in cats is high and cats can remain infected for months to
years (19). However, the clinical significance of B. henselae infection in cats remains controversial. Several studies
have not identified disease manifestations in experimentally infected
cats (1, 28). Others have documented clinical
abnormalities, including fever, anorexia, lethargy, lymphadenopathy,
muscle pain, and neurologic dysfunction, in cats following experimental
infection (12, 18, 26). It has been suggested that these
disparate results are due to differences in virulence among strains of
B. henselae (26). The pathogenesis of B. henselae infection in cats and the determinants of organism
virulence for this species require further elucidation.
In the present study, we utilized in vitro culture systems to examine
B. henselae's ability to invade and persist in feline fetal
brain cells. We investigated the relative susceptibilities of
astrocytes and microglial cells to infection with B. henselae and assessed the ultrastructural effects of infection.
(This study was presented in part at the 18th Annual Forum of the
American College of Veterinary Internal Medicine, 25 to 28 May 2000, Seattle, Wash.)
Fetuses with a gestational age of 40 to 60 days were obtained from
random-source pregnant cats following routine ovariohysterectomy. Brains were aseptically removed in toto and placed in a petri dish
containing Hanks' balanced salt solution (Mediatech, Herndon, Va.).
The meninges were carefully removed, and the brains were washed three
times in Hanks' balanced salt solution. Brain tissue was minced with
scissors in Dulbecco's modified enriched medium (Mediatech)
supplemented with 10% fetal bovine serum (Mediatech) and mechanically
dissociated by passage through a 40-mesh tissue sieve (Bellco Glass,
Vineland, N.J.). The dissociated tissue was centrifuged at 3,000 × g for 5 min and the supernatant was discarded. The pellet
was resuspended in medium and seeded into 75-cm2
polystyrene tissue culture flasks (Fisher Scientific, Pittsburgh, Pa.).
Cells were incubated at 37°C in 5% CO2. The cultures
were left undisturbed for 5 days, at which time the medium was changed to remove cell debris. The medium was changed every 3 to 5 days thereafter.
The mixed cell culture reached confluence after a minimum of 14 to 21 days, with the astrocytes forming a monolayer that tightly adhered to
the flask. The microglia were located more superficially and remained
loosely adhered to the underlying astrocyte monolayer. Microglia were
removed by mechanical shaking. Flasks were placed on an orbital shaker
at 150 rpm for 1 h, after which the culture supernatant containing
microglial cells was aspirated and centrifuged at 300 × g
for 5 min. The pellet was resuspended in medium and seeded onto
single-chamber slides (Nunc, Naperville, Ill.) and into
25-cm2 flasks (Fisher Scientific) to yield cultures
enriched (>95%) in microglia. Cells were confirmed to be
microglia based on characteristic morphology, uptake of
1,1'-dioctadecyl-3,3,3',3'-tetramethyl indocarbocyanine perchlorate-labeled acetylated low-density lipoprotein
(Biomedical Technologies, Stoughton, Mass.), and positive staining with
nonspecific esterase (Sigma Diagnostic, St. Louis, Mo.)
(8).
The astrocyte monolayer remaining in the flasks was briefly incubated
in 0.25% trypsin (Mediatech) and reseeded onto single-chamber slides
and into 25-cm2 flasks to yield cultures enriched (90 to
95%) in astrocytes. Cells were confirmed to be astrocytes by
characteristic morphology and positive immunohistochemical staining
with glial fibrillary acidic protein (Dako, Santa Barbara, Calif.)
utilizing an ABC immunoperoxidase technique (Vector Laboratories,
Burlingame, Calif.).
Microglia- and astrocyte-enriched cell cultures were infected 5 days
after being established with isolate NCSU 93-F029 of B. henselae. The organism had originally been isolated from the blood
of a cat that displayed signs of transient neurological dysfunction
subsequent to its owner developing cat scratch disease. The B. henselae isolate was passaged three times in Vero cell culture.
Quantification of CFU on trypticase soy agar with 5% rabbit blood
(BBL, Becton Dickinson and Co., Cockeysville, Md.) yielded a count of
1.5 × 1010 CFU/ml. One-milliliter aliquots of the
harvest were stored frozen at Giménez stains.
Chamber slides were harvested at 1, 4, 7, 11, and 14 days after inoculation and were stained by the
Giménez method (11). Slides were rinsed in
phosphate-buffered saline (PBS), fixed in methanol for 15 min, and air
dried. Fixed slides were covered with a solution of 1% basic fuchsin
and phenol (Sigma-Aldrich Chemical, St. Louis, Mo.) for 90 s and
then rinsed in tap water for 30 s. The slides were counterstained
with 1% malachite green oxalate (Sigma-Aldrich Chemical) for 9 s
and washed in tap water for 10 s, and then the counterstaining
sequence was repeated. The air-dried slides were observed with light
microscopy. No organisms were observed in microglial cells at 1 or 4 days postinoculation. However, at 7 days postinoculation, organisms
were observed within the cytoplasm of the microglial cell. The
bacterial staining imparted a pink color to the cell cytoplasm, and
aggregates of organisms could be visualized in a perinuclear location
(Fig. 1A). Positive staining persisted in
microglial cells at 11 and 14 days postinoculation. There was no
evidence of cellular pathology; i.e., there were no changes in cellular
morphology or evidence of cell loss in infected cultures. Bacterial
organisms were never identified within astrocytes at any time
throughout the course of the experiment (Fig. 1B).
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.564-569.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Infection of Fetal Feline Brain Cells in Culture
with Bartonella henselae
and
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
70°C. Each aliquot was diluted in 10 ml of medium, and 1 ml of the suspension (1.5 × 109
CFU) was added to coat the bottom of each vessel. The cultures were
rocked at room temperature for 4 h, after which the inoculum was
removed and replaced with fresh medium. Parallel-inoculated Vero cell
cultures served as the positive control and uninfected brain cell
cultures derived from the same fetal tissue served as the negative
control for each experiment. Following inoculation, all cell cultures
were incubated at 37°C with 5% CO2.

View larger version (42K):
[in a new window]
FIG. 1.
(A) Microglial-cell-enriched cultures, 14 days after
inoculation with B. henselae, display evidence of infection
based on positive Giménez staining for bacteria. Bacterial
aggregates are identified in the perinuclear region of the cells
(arrows). (B) Astrocyte-enriched cultures, 14 days after inoculation
with B. henselae, reveal no evidence of cellular infection
when stained by the Giménez method. Bars, 25 µm.
Isolation of organisms from cell culture.
At 14 and 28 days
after inoculation, gentamicin sulfate (Mediatech) was added to the
flasks at a concentration of 250 µg/ml and the cultures were allowed
to incubate for 3 h at 37°C. This was done to selectively remove
any extracellular bacteria from the culture system. Gentamicin is not
taken up by mammalian cells, and therefore bacteria that have entered
cells are presumably protected from its antimicrobial effects. Cultures
were then washed with sterile PBS, and cells were scraped from the
flasks and spun gently to form a pellet. The pellet was washed twice
and resuspended in 1 ml of sterile PBS. The cell suspension was lysed
by freezing at
70°C for 3 min followed by a thaw at room
temperature. The freeze-thaw sequence was repeated and the lysate was
streaked onto trypticase soy plates with 5% rabbit blood (BBL, Becton
Dickinson and Co.). The agar plates were incubated at 37°C with 5%
CO2. Bacterial colonies were isolated 7 days after plating
lysate from microglial cells harvested at 14 and 28 days
postinoculation. Bacterial culture of the cell lysate derived from
Bartonella-inoculated astrocyte cultures yielded no growth
after 14 days of incubation.
Electron microscopy.
Cells were harvested at 7 and 14 days
after inoculation, and cultures were fixed with McDowell and Trump's
solution (4% formaldehyde and 1% glutaraldehyde in phosphate buffer)
and processed according to standard techniques for transmission
electron microscopy (9). Examination of microglial cells
in culture revealed intracellular bacillary organisms with morphologic
characteristics similar to those previously reported for
Bartonella species (3, 6, 17) (Fig.
2). The organisms were short, pleomorphic
rods measuring 0.1 to 0.4 µm in width and 0.5 to 1.0 µm in length.
They were often seen in clusters within the cell cytoplasm. A double
membrane was identified surrounding the bacteria in some sections, and vacuoles were present within a small number of the organisms. No
morphologic changes were apparent in infected cells compared to cells
in uninoculated cultures.
|
) (7). The expression of IL-1 and TNF-
by
microglia has been shown to attract inflammatory cells into the CNS and
to stimulate endothelial cells and astrocytes to proliferate and
produce other soluble factors (36). An increase in local cytokine production can be toxic to cellular elements within the CNS,
as demonstrated by the effects of TNF-
on myelin and myelin-forming cells (33). Both IL-1 and TNF-
are known to induce
fever and mediate inflammation and acute-phase responses, and they are
cytotoxic to certain neural cell types in vitro, all of which may play
a role in the development of encephalopathy (36).
Infection may also induce alteration of the normal structural
associations that exist between neural cells in vivo. Microglia develop
extensive branching of cell processes around neurons, and the close
physical proximity between microglia and neurons suggests a functional
significance to this association (7). Alterations in
infected microglia may induce profound functional effects on neurons by
disrupting the normal microglial-neuronal interactions. These types of
structural alterations would not be appreciated in the cell culture
system utilized for the present study.
In conclusion, we have determined that feline microglial cells in
culture support infection of B. henselae. It appears likely that the organism may remain sequestered in these cells, allowing for
the development of persistent infections. Microglia may therefore be
involved in the pathogenesis of CNS disease associated with the
organism, as this cell type plays an important role in the regulation
of local immune responses. Additional study into the cell-specific
response to infection is necessary to further elucidate the role of
microglia in the development of CNS disease due to B. henselae infection.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the North Carolina State University College of Veterinary Medicine State Research Funds and the North Carolina State University Faculty Research and Professional Development Fund.
We acknowledge the Electron Microscopy Laboratory at North Carolina State University College of Veterinary Medicine for the preparation of the electron micrographs.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough St., Raleigh, NC 27606. Phone: (919) 513-6231. Fax: (919) 513-6336. E-mail: Karen_Munana{at}ncsu.edu.
Present address: Blue Ridge Pharmaceuticals, Greensboro, NC 27410.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Abbott, R. C., B. B. Chomel, R. W. Kasten, K. A. Floyd-Hawkins, Y. Kikuchi, J. E. Koehler, and N. C. Pedersen. 1997. Experimental and natural infection with Bartonella henselae in domestic cats. Comp. Immunol. Microbiol. Infect. Dis. 20:41-51[CrossRef][Medline]. |
| 2. | Brazis, P. W., H. R. Stokes, and F. R. Ervin. 1986. Optic neuritis in cat scratch disease. J. Clin. Neurol. Opththalmol. 6:172-174. |
| 3. | Breitschwerdt, E. B., D. L. Kordick, D. E. Malarkey, B. Keene, T. L. Hadfield, and K. Wilson. 1995. Endocarditis in a dog due to infection with a novel Bartonella subspecies. J. Clin. Microbiol. 33:154-160[Abstract]. |
| 4. |
Carithers, H. A., and A. M. Margileth.
1991.
Cat scratch disease. Acute encephalopathy and other neurologic manifestations.
Am. J. Dis. Child.
145:98-101 |
| 5. | Conley, T. L., L. Slater, and K. Hamilton. 1994. Rochalimaea species stimulate human endothelial cell proliferation and migration in vitro. J. Lab. Clin. Med. 124:521-528[Medline]. |
| 6. | Dehio, C., M. Meyer, J. Berger, H. Schwarz, and C. Lanz. 1997. Interaction of Bartonella henselae with endothelial cells results in bacterial aggregation on the cell surface and the subsequent engulfment and internalisation of the bacterial aggregate by a unique structure, the invasome. J. Cell Sci. 110:2141-2154[Abstract]. |
| 7. | Dickson, D. W., L. A. Mattiace, K. Kure, K. Hutchins, W. D. Lyman, and C. F. Brosnan. 1991. Microglia in human disease, with an emphasis on acquired immunodeficiency syndrome. Lab. Investig. 64:135-156[Medline]. |
| 8. | Dow, S. W., M. J. Dreitz, and E. A. Hoover. 1992. Feline immunodeficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells. Vet. Immunol. Immunopathol. 35:23-35[CrossRef][Medline]. |
| 9. | Dykstra, M. J. 1985. A manual of applied techniques for biological electron microscopy. Plenum Publishing Corp., New York, N.Y. |
| 10. |
Freyer, D.,
R. Manz,
A. Ziegenhorn,
M. Weih,
K. Angstwurm,
W. D. Docke,
A. Meisel,
R. R. Schumann,
G. Schonfelder,
U. Dirnagl, and J. R. Weber.
1999.
Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops.
J. Immunol.
163:4308-4314 |
| 11. | Giménez, D. F. 1964. Staining rickettsiae in yolk sac cultures. Stain Technol. 39:135-140[Medline]. |
| 12. | Guptill, L., L. Slater, C. Wu, T. Lin, L. Glickman, D. Welch, and H. HogenEsch. 1997. Experimental infection of young cats with the zoonotic organism Bartonella henselae. J. Infect. Dis. 176:206-216[Medline]. |
| 13. | Jameson, P., C. Greene, R. Regnery, M. Dryden, A. Marks, J. Brown, J. Cooper, B. Glaus, and R. Greene. 1995. Prevalence of Bartonella henselae antibodies in pet cats throughout regions of North America. J. Infect. Dis. 172:1145-1149[Medline]. |
| 14. |
Jensen, W. A.,
M. Z. Fall,
J. Rooney,
D. L. Kordick, and E. B. Breitschwerdt.
2000.
Rapid identification and differentiation of Bartonella species using a single-step PCR assay.
J. Clin. Microbiol.
38:1717-1722 |
| 15. | Karem, K. L., K. A. Dubois, S. L. McGill, and R. L. Regnery. 1999. Characterization of Bartonella henselae-specific immunity in BALB/c mice. Immunology 97:352-358[CrossRef][Medline]. |
| 16. |
Koehler, J. E.,
C. A. Glaser, and J. W. Tappero.
1994.
Rochalimaea henselae infection: a new zoonosis with the domestic cat as a reservoir.
JAMA
271:531-535 |
| 17. | Kordick, D. L., and E. B. Breitschwerdt. 1995. Intraerythrocytic presence of Bartonella henselae. J. Clin. Microbiol. 33:1655-1656[Abstract]. |
| 18. | Kordick, D. L., and E. B. Breitschwerdt. 1997. Relapsing bacteremia after blood transmission of Bartonella henselae to cats. Am. J. Vet. Res. 58:492-497[Medline]. |
| 19. |
Kordick, D. L.,
T. T. Brown,
K. Shin, and E. B. Breitschwerdt.
1999.
Clinical and pathologic evaluation of chronic Bartonella henselae or Bartonella clarridgeiae infection in cats.
J. Clin. Microbiol.
37:1536-1547 |
| 20. | Kordick, D. L., K. H. Wilson, D. J. Sexton, T. L. Hadfield, H. A. Berkhoff, and E. B. Breitschwerdt. 1995. Prolonged Bartonella bacteremia in cats associated with cat-scratch disease patients. J. Clin. Microbiol. 33:3245-3251[Abstract]. |
| 21. |
Lewis, D. W., and S. H. Tucker.
1986.
Central nervous system involvement in cat scratch disease.
Pediatrics
77:714-721 |
| 22. | Lucey, D., M. J. Dolan, C. W. Moss, M. Garcia, D. G. Holis, S. Wegner, G. Morgan, R. Almeida, D. Leong, K. S. Greisen, et al. 1992. Relapsing illness due to Rochalimaea henselae in immunocompetent hosts: implication for therapy and new epidemiological associations. Clin. Infect. Dis. 14:683-688[Medline]. |
| 23. |
Mehock, J. R.,
C. E. Greene,
F. C. Gherardini,
T. W. Hahn, and D. C. Krause.
1998.
Bartonella henselae invasion of feline erythrocytes in vitro.
Infect. Immun.
66:3462-3466 |
| 24. | Murakawa, G. J. 1997. Pathogenesis of Bartonella henselae in cutaneous and systemic disease. J. Am. Acad. Dermatol. 37:775-776[Medline]. |
| 25. |
Musso, D.,
M. Drancourt, and D. Raoult.
1995.
Lack of bactericidal effects of antibiotics except aminoglycosides on Bartonella (Rochalimaea) henselae.
J. Antimicrob. Chemother.
36:101-108 |
| 26. |
O'Reilly, K. L.,
R. W. Bauer,
R. L. Freeland,
L. D. Foil,
K. J. Hughes,
K. R. Rohde,
A. F. Roy,
R. W. Stout, and P. C. Triche.
1999.
Acute clinical disease in cats following infection with a pathogenic strain of Bartonella henselae (LSU16).
Infect. Immun.
67:3066-3072 |
| 27. | Pickerill, R. G., and J. E. Milder. 1986. Transverse myelitis associated with cat scratch disease in an adult. JAMA 246:2840-2841. |
| 28. | Regnery, R. L., J. A. Rooney, A. M. Johnson, S. L. Nesby, P. Manzewitsch, K. Beaver, and J. G. Olson. 1996. Experimentally induced Bartonella henselae infections followed by challenge exposure and antimicrobial therapy in cats. Am. J. Vet. Res. 57:1714-1719[Medline]. |
| 29. | Relman, D. A. 1998. Are all Bartonella henselae strains created equal? Clin. Infect. Dis. 26:1300-1301[Medline]. |
| 30. |
Schwartzmann, W. A.,
M. Patnaik,
N. E. Barka, and J. B. Peter.
1994.
Rochalimaea antibodies in HIV-associated neurologic disease.
Neurology
44:1312-1316 |
| 31. | Schwartzmann, W. A., M. Patnaik, F. J. Angulo, B. R. Vusscher, E. N. Miller, and J. B. Peter. 1995. Bartonella (Rochalimaea) antibodies, dementia and cat ownership among men infected with human immunodeficiency virus. Clin. Infect. Dis. 21:954-959[Medline]. |
| 32. |
Selby, G., and G. L. Walker.
1979.
Cerebral arteritis in cat scratch disease.
Neurology
29:1413-1418 |
| 33. | Selmaj, J. W., and C. S. Raine. 1988. Tumor necrosis factor mediated myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339-346[CrossRef][Medline]. |
| 34. | Spach, D. H., L. A. Panther, D. R. Thorning, J. E. Dunn, J. J. Plorde, and R. A. Miller. 1992. Intracerebral bacillary angiomatosis in a patient infected with human immunodeficiency virus. Ann. Intern. Med. 116:740-742. |
| 35. |
Tappero, J. W.,
J. Mohle-Boetani,
J. E. Koehler,
B. Swaiminathan,
T. G. Berger,
P. E. LeBoit,
L. L. Smith,
J. D. Wenger,
R. W. Pinner,
C. A. Kemper, and A. L. Rinegold.
1993.
The epidemiology of bacillary angiomatosis and bacillary peliosis.
JAMA
269:770-775 |
| 36. | Tyor, W. R., J. D. Glass, J. W. Griffin, P. S. Becker, J. C. McArthur, L. Bezman, and D. E. Griffin. 1992. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:349-360[CrossRef][Medline]. |
| 37. |
Wear, D. J.,
A. M. Margileth,
G. W. Fisher,
C. J. Schlagel, and F. M. King.
1983.
Cat scratch disease: a bacterial infection.
Science
221:1403-1405 |
| 38. |
Wheeler, S. W.,
S. M. Wolf, and E. A. Steinberg.
1997.
Cat-scratch encephalopathy.
Neurology
49:876-878 |
| 39. |
Zangwill, K. M.,
D. H. Hamilton,
B. A. Perkins,
R. L. Regnery,
B. D. Plikaytis,
J. L. Hadler,
M. L. Carter, and J. D. Wenger.
1993.
Cat scratch disease in Connecticut: epidemiology, risk factors, and evaluation of a new diagnostic test.
N. Engl. J. Med.
329:8-13 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»